IEEE Transactions on Computational Biology and BioinformaticsDevelopmental BiologyPeer-reviewed journal article
Vina-GPU 2.1: towards further optimizing docking speed and precision of AutoDock Vina and its derivatives
Shidi TangiD, Ji DingiD, Xiangyu Zhu, Zheng WangiD, Haitao ZhaoiD, Jiansheng WuiD
Abstract
AutoDock Vina and its derivatives have established themselves as a prevailing pipeline for virtual screening in contemporary drug discovery. Our Vina-GPU method leverages the parallel computing power of GPUs to accelerate AutoDock Vina, and Vina-GPU 2.0 further enhances the speed of AutoDock Vina and its derivatives. Given the prevalence of large virtual screens in modern drug discovery, the improvement of speed and accuracy in virtual screening has become a longstanding challenge. In this study, we propose Vina-GPU 2.1, aimed at enhancing the docking speed and precision of AutoDock Vina and its derivatives through the integration of novel algorithms to facil-itate improved docking and virtual screening outcomes. Building upon the foundations laid by Vina-GPU 2.0, we introduce a novel algorithm, namely Reduced Iteration and Low Complexity BFGS (RILC-BFGS), designed to expedite the most time-consuming operation. Additionally, we implement grid cache optimization to further enhance the docking speed. Furthermore, we employ optimal strategies to individually optimize the structures of ligands, receptors, and binding pockets, thereby enhancing the docking precision. To assess the performance of Vina-GPU 2.1, we conduct extensive virtual screening experiments on three prominent targets, utilizing two fundamental compound libraries and seven docking tools. Our results demonstrate that Vina-GPU 2.1 achieves an average 4.97-fold acceleration in docking speed and an average 342% improvement in EF1% compared to Vina-GPU 2.0. The source code and tools for Vina-GPU 2.1 are freely available at https://github.com/DeltaGroupNJUPT/Vina-GPU-2.1, accompanied by comprehensive instructions and illustrative examples.
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: statistical model
- approach: optimal transport
- Citations
- 42
- FWCI
- 8.88
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NeuralDock: Rapid and conformation-agnostic docking of small molecules
C. M. Sha, J. Wang, N. V. Dokholyan·bioRxiv·Aug 20, 2021
- An artificial intelligence accelerated virtual screening platform for drug discovery
Guangfeng Zhou, Domnița-Valeria Rusnac, … Frank DiMaio·Nature CommunicationsPeer-reviewed·Sep 5, 2024
- DENVIS: scalable and high-throughput virtual screening using graph neural networks with atomic and surface protein pocket features
Agamemnon Krasoulis, Nick Antonopoulos, … Stavros Theodorakis·Journal of Chemical Information and ModelingPeer-reviewed·Sep 26, 2022
- G-screen: Scalable Protein-Aware Virtual Screening through Flexible Ligand Alignment
Nuri Jung, Hahnbeom Park, … Chaok Seok·Journal of CheminformaticsPeer-reviewed·Sep 16, 2026
- GalaxyVS: Exploring 100-Billion Compounds in Seconds
Xin Hong, Peishun Li, … Yanyan Lan·bioRxiv·Jun 3, 2026
- Blind Virtual Screening at Scale: A Scalable End-to-End Pipeline for Blind Docking and Affinity Prediction
Matthew Parks, Xin Yu, … Hok Hei Tam·bioRxiv·Oct 10, 2025